Experts expect change in strategy for a focus on high-margin products, rather than multiple brand launches
Drugmakers in Medak, including large Indian firms Dr Reddy's Laboratories, Aurobindo Pharma and Hetero Drugs
Union government is allegedly cutting down support to bulk drug manufacturing from a proposed outlay of Rs 5,000 crore to nearly Rs 600 crore